+1-947-333-4405
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Review Article
Meningococcal Disease
| Becka CM1* and Chacón-Cruz E2 | |
| 1Department of Medicine, Xochicalco University, School of Medicine, Tijuana, Baja California, Mexico | |
| 2Department of Medicine, Tijuana General Hospital, Baja California, Mexico | |
| Corresponding Author : | Chandra M Becka Xochicalco University, School of Medicine Tijuana, Baja California, Mexico Tel: 1-208-546-2500 E-mail: cmbecka@gmail.com |
| Received: August 04, 2015 Accepted: September 16, 2015 Published: September 22, 2015 | |
| Citation: Becka CM and Chacón-Cruz E (2015) Meningococcal Disease. J Infect Dis Ther 3:235. doi:10.4172/2332-0877.1000235 | |
| Copyright: © 2015 Becka et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | |
| Related article at Pubmed, Scholar Google | |
Abstract
Meningococcal disease is one of the great bacterial threats to human health. Even in the age of antibiotics andvaccines, it remains one of the primary causes of bacterial meningitis worldwide. The causative agent, Neisseria meningitidis, is a gram negative, fastidious diplococcic that commensally inhabits the human nasopharynx.Transmission occurs through close contact with aerosol and respiratory secretions of infected carriers. The disease occurs both sporadically and in epidemics. Endemic areas with high carriage rates have also been identified. The purpose of this review is to examine the current status of the disease and identify the obstacles that the scientific community will encounter in the face of technological advances, changing environment and disease evolution.
